![NewAmsterdam Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://marketsgonewild.com/wp-content/uploads/2024/12/NewAmsterdam-Pharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4-600x360.jpg)
NewAmsterdam Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NewAmsterdam Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NAARDEN, The Netherlands and MIAMI, Nov. 01, 2024 (GLOBE NEWSWIRE) NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for…